Back to search results

Mobile Intervention for Chronic Pain and Health in Older Adults

This study is testing a program called MORPH, which uses coaching and digital tools to help older adults with chronic pain, osteoarthritis, and obesity improve their diet and activity. We're comparing MORPH to a group that only receives a body weight scale and activity monitor. We want to see if MORPH can help people increase their daily steps over 18 months. You might be able to join if you are 65 or older, have a BMI (Body Mass Index) between 30 and 45 (or higher with doctor's approval), haven't had major weight changes recently, have knee or hip osteoarthritis, live independently, and are not very active. The study is currently unclear on its recruitment status and plans to enroll 200 people.

Study design
This is an interventional study planning to enroll 200 participants. It compares a behavioral intervention (MORPH) to a group that only receives measurement tools.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Your daily steps will be measured at the start, after 6 months of the intervention, and again after 18 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06623669

A Mobile Intervention to Reduce Pain and Improve Health-III

Recruiting
PHASE2Ages 65+InterventionalTreatment
Wake Forest University
~200 participants
Updated 2026-02-20 on ClinicalTrials.gov
What's tested:MORPHMeasurement Only

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Daily steps
Measured over Baseline, after 6 months of intervention, after 18 months of intervention

Conditions

Chronic Pain
Osteoarthritis
Obesity and Overweight
Inactivity

Explore related trials

Chronic PainObesityOsteoarthritis

Where it's being run

1 sites across 1 states
North Carolina1

Study leadership

  • Jason Fanning, PhD · PRINCIPAL_INVESTIGATOR · Wake Forest University
  • Amber Brooks, MD · PRINCIPAL_INVESTIGATOR · Wake Forest University Health Sciences

Who to contact

Deja O Dobson, MS
[email protected]
3367585042
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Aged 65+ years
Body mass index of 30-45 kg/m2 or \>45 kg/m2 with physician's approval
No loss or gain of more than 5% body mass in previous 6 months
Presence of knee or hip osteoarthritis as ascertained via the Roux questionnaire
Independently living
Low active (i.e., not participating in regular resistance training and/or \>20 mins/day of aerobic exercise on more than 2 days/week in past 3 months as ascertained via a modified CHAMPS questionnaire)
Have no contraindication for safe and optimal participation in exercise based on EASY screening (pertaining to chest pain and discomfort during physical activity, dizziness or light headedness, or frequent falls and use of assistive devices)
Not currently using a weight loss medication (medications for diabetes management are permitted if weight stable)
Approved for participation by medical director
Willing to provide informed consent and agree to all study procedures and assessments.

Exclusion

Reside in skilled nursing facility, rehab or assisted living environment
History of pharmacologic treatment for a psychiatric disorder other than depression/anxiety within past year
Current untreated and/or unstable clinical depression or anxiety (Patient Health Questionnaire (PHQ-9) \>15)
Hospitalization for psychiatric event within past year prior to screening
History of mild cognitive impairment or dementia
Cognitive impairment (\<32) on Modified Telephone Interview for Cognitive Status survey (TICS-M)
Hearing or visual impairment that would preclude use of the videoconferencing software
Severe arthritis or other musculoskeletal disorder that is a contraindication for safe walking
Presently undergoing treatment for orthopedic fracture
Currently using a weight loss medication (medications for diabetes management are permitted if weight stable)
Contraindication based on EASY screening (pertaining to chest pain and discomfort during physical activity, dizziness or light headedness, or frequent falls and use of assistive devices) without physician approval
Joint replacement or other orthopedic surgery in past 6 months
Joint replacement or other orthopedic surgery planned in next 18 months
Have a diagnosis of uncontrolled hypertension; current or recent past (within 1 year) severe symptomatic heart disease, uncontrolled angina, stroke, chronic respiratory disease other than asthma or COPD, any disease requiring oxygen use, neurological or hematological disease; cancer requiring current treatment, except non-melanoma skin cancers; kidney failure requiring dialysis; have a Katz ADL disability; or engage in heavy alcohol use \>14 drinks/week.
Current participation in other research study with a prospective intervention
Unable/unwilling to commit to study protocol, including random assignment and use of technology tools
Unable/unwilling to attend three virtual testing appointments

What this trial measures

  • Daily stepsBaseline, after 6 months of intervention, after 18 months of intervention

    Daily steps measured over one week via the ActivPAL accelerometer